# Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure

> **NCT01084837** · PHASE2 · COMPLETED · sponsor: **PETHEMA Foundation** · enrollment: 60 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** velcade

## Key facts

- **NCT ID:** NCT01084837
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-09
- **Final completion:** 2013-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084837, "Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01084837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*